Itching and watery eyes, perhaps so swollen that it’s actually scary. Ragged and wheezy breathing. Sneezes so constant the shoulders and back begin to ache. For those with environmental allergies, this is their reality for most of the year, from spring until the first frost. When you’re the parent of a child who suffers from… Read More: A Cure for Allergies? Chicagoland Pediatrician May Have The Key »
July 23, 2021 As public health officials keep track of the contagious Delta variant of COVID-19 across the U.S., the CDC is also watching for a potential outbreak of another virus — monkeypox. More than 200 people in 27 states are being monitored for possible exposure after they had contact with an American who contracted… Read More: CDC Monitors Potential Monkeypox Exposure in U.S. »
FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More: FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in… »
More than 18 months after Sutter Health agreed to a tentative settlement in a closely watched antitrust case joined by the California Attorney General’s Office, the judge presiding over the case indicated she would sign off on the terms, pending agreement on attorney fees. The nonprofit health care giant, based in Sacramento, stood accused of… Read More: After 18 Months, Sutter Antitrust Settlement Finally Poised for Formal… »